171 related articles for article (PubMed ID: 20609435)
1. Challenges using motivational interviewing as an adjunct to exposure therapy for obsessive-compulsive disorder.
Simpson HB; Zuckoff AM; Maher MJ; Page JR; Franklin ME; Foa EB; Schmidt AB; Wang Y
Behav Res Ther; 2010 Oct; 48(10):941-8. PubMed ID: 20609435
[TBL] [Abstract][Full Text] [Related]
2. Adding motivational interviewing to exposure and ritual prevention for obsessive-compulsive disorder: an open pilot trial.
Simpson HB; Zuckoff A; Page JR; Franklin ME; Foa EB
Cogn Behav Ther; 2008; 37(1):38-49. PubMed ID: 18365797
[TBL] [Abstract][Full Text] [Related]
3. Patient adherence predicts outcome from cognitive behavioral therapy in obsessive-compulsive disorder.
Simpson HB; Maher MJ; Wang Y; Bao Y; Foa EB; Franklin M
J Consult Clin Psychol; 2011 Apr; 79(2):247-252. PubMed ID: 21355639
[TBL] [Abstract][Full Text] [Related]
4. Patient adherence and treatment outcome with exposure and response prevention for OCD: Which components of adherence matter and who becomes well?
Wheaton MG; Galfalvy H; Steinman SA; Wall MM; Foa EB; Simpson HB
Behav Res Ther; 2016 Oct; 85():6-12. PubMed ID: 27497840
[TBL] [Abstract][Full Text] [Related]
5. Behavioral avoidance predicts treatment outcome with exposure and response prevention for obsessive-compulsive disorder.
Wheaton MG; Gershkovich M; Gallagher T; Foa EB; Simpson HB
Depress Anxiety; 2018 Mar; 35(3):256-263. PubMed ID: 29394511
[TBL] [Abstract][Full Text] [Related]
6. Development of a patient adherence scale for exposure and response prevention therapy.
Simpson HB; Maher M; Page JR; Gibbons CJ; Franklin ME; Foa EB
Behav Ther; 2010 Mar; 41(1):30-7. PubMed ID: 20171325
[TBL] [Abstract][Full Text] [Related]
7. Change in obsessive-compulsive symptoms mediates subsequent change in depressive symptoms during exposure and response prevention.
Zandberg LJ; Zang Y; McLean CP; Yeh R; Simpson HB; Foa EB
Behav Res Ther; 2015 May; 68():76-81. PubMed ID: 25824533
[TBL] [Abstract][Full Text] [Related]
8. Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: a preliminary study.
Merlo LJ; Storch EA; Lehmkuhl HD; Jacob ML; Murphy TK; Goodman WK; Geffken GR
Cogn Behav Ther; 2010; 39(1):24-7. PubMed ID: 19675960
[TBL] [Abstract][Full Text] [Related]
9. Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? A randomized controlled trial in a community setting.
Rector NA; Richter MA; Katz D; Leybman M
Br J Clin Psychol; 2019 Mar; 58(1):1-18. PubMed ID: 29984550
[TBL] [Abstract][Full Text] [Related]
10. Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder.
Simpson HB; Foa EB; Wheaton MG; Gallagher T; Gershkovich M; Schmidt AB; Huppert JD; Campeas RB; Imms PA; Cahill SP; DiChiara C; Tsao SD; Puliafico AC; Chazin D; Asnaani A; Moore K; Tyler J; Steinman SA; Sanchez-LaCay A; Capaldi S; Snorrason I; Turk-Karan E; Vermes D; Kalanthroff E; Pinto A; Hahn CG; Xu B; Van Meter PE; Katechis M; Scodes J; Wang Y
Behav Res Ther; 2021 Aug; 143():103890. PubMed ID: 34089924
[TBL] [Abstract][Full Text] [Related]
11. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
[TBL] [Abstract][Full Text] [Related]
12. Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder.
Pagliaccio D; Middleton R; Hezel D; Steinman S; Snorrason I; Gershkovich M; Campeas R; Pinto A; Van Meter P; Simpson HB; Marsh R
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20346-20353. PubMed ID: 31548396
[TBL] [Abstract][Full Text] [Related]
13. The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder.
Williams MT; Farris SG; Turkheimer EN; Franklin ME; Simpson HB; Liebowitz M; Foa EB
J Anxiety Disord; 2014 Aug; 28(6):553-8. PubMed ID: 24983796
[TBL] [Abstract][Full Text] [Related]
14. Exposure and response prevention helps adults with obsessive-compulsive disorder who do not respond to pharmacological augmentation strategies.
McLean CP; Zandberg LJ; Van Meter PE; Carpenter JK; Simpson HB; Foa EB
J Clin Psychiatry; 2015 Dec; 76(12):1653-7. PubMed ID: 26613263
[TBL] [Abstract][Full Text] [Related]
15. Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder.
Foa EB; Simpson HB; Rosenfield D; Liebowitz MR; Cahill SP; Huppert JD; Bender J; McLean CP; Maher MJ; Campeas R; Hahn CG; Imms P; Pinto A; Powers MB; Rodriguez CI; Van Meter PE; Vermes D; Williams MT
J Clin Psychiatry; 2015 Apr; 76(4):440-6. PubMed ID: 25375780
[TBL] [Abstract][Full Text] [Related]
16. Acceptability, Feasibility, and Effectiveness of Internet-Based Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in New York.
Patel SR; Wheaton MG; Andersson E; Rück C; Schmidt AB; La Lima CN; Galfavy H; Pascucci O; Myers RW; Dixon LB; Simpson HB
Behav Ther; 2018 Jul; 49(4):631-641. PubMed ID: 29937263
[TBL] [Abstract][Full Text] [Related]
17. Response versus remission in obsessive-compulsive disorder.
Simpson HB; Huppert JD; Petkova E; Foa EB; Liebowitz MR
J Clin Psychiatry; 2006 Feb; 67(2):269-76. PubMed ID: 16566623
[TBL] [Abstract][Full Text] [Related]
18. Obsessive compulsive personality disorder as a predictor of exposure and ritual prevention outcome for obsessive compulsive disorder.
Pinto A; Liebowitz MR; Foa EB; Simpson HB
Behav Res Ther; 2011 Aug; 49(8):453-8. PubMed ID: 21600563
[TBL] [Abstract][Full Text] [Related]
19. Patient adherence as a predictor of acute and long-term outcomes in concentrated exposure treatment for difficult-to-treat obsessive-compulsive disorder.
Tjelle K; Opstad HB; Solem S; Kvale G; Wheaton MG; Björgvinsson T; Hansen B; Hagen K
BMC Psychiatry; 2024 Apr; 24(1):327. PubMed ID: 38689256
[TBL] [Abstract][Full Text] [Related]
20. "Phobie à deux" and other reasons why clinicians do not apply exposure with response prevention in patients with obsessive-compulsive disorder.
Moritz S; Külz A; Voderholzer U; Hillebrand T; McKay D; Jelinek L
Cogn Behav Ther; 2019 Mar; 48(2):162-176. PubMed ID: 30064295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
